Dr Reddys Laboratories (RDY) Other Non Operating Income (2009 - 2026)

Dr Reddys Laboratories has reported Other Non Operating Income for 18 years, with the latest figure at -$8.9 million in Q2 2026.

• On a quarterly basis, Other Non Operating Income fell 3.36% year-over-year to -$8.9 million in Q2 2026; TTM through Jun 2026 was -$85.9 million, a 58.94% decrease from a year earlier, with the FY2026 full-year figure at -$81.0 million, down 58.82% from the prior year.
• Other Non Operating Income was -$8.9 million for Q2 2026 at Dr Reddys Laboratories, up from -$37.7 million in the prior quarter.
• The five-year high for Other Non Operating Income was $11.6 million in Q4 2023, with the low at -$78.1 million in Q2 2022.
• Average Other Non Operating Income over 5 years is -$13.3 million, with a median of -$8.6 million recorded in 2025.
• The largest YoY upside for Other Non Operating Income was 378.34% in 2022 against a maximum downside of 1082.83% in 2022.
• Over 5 years, Other Non Operating Income stood at $8.9 million in 2022, then increased by 29.72% to $11.6 million in 2023, then sank by 144.96% to -$5.2 million in 2024, then sank by 66.3% to -$8.6 million in 2025, then dropped by 3.22% to -$8.9 million in 2026.
• The last three Other Non Operating Income figures came in at -$8.9 million (Q2 2026), -$37.7 million (Q1 2026), and -$8.6 million (Q4 2025), per Business Quant data.